Actively Recruiting

Phase Not Applicable
Age: 22Years +
All Genders
ID05705453

Epidural Spinal Cord Stimulation After Neurologic Damage: Long-Term Outcomes Over 10 Years

Led by University of Minnesota · Updated on 2026-04-08

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the long-term effects of chronic epidural spinal cord stimulation to help restore voluntary movement in adults with stable spinal cord injuries. This study focuses on patients with neurological damage below the C5 level and aims to assess changes in muscle activity power over a 10-year period. The study is sponsored by the University of Minnesota and involves ongoing monitoring and adjustment of spinal cord stimulator settings. Participants will receive epidural spinal cord stimulation using an implanted device that is already FDA approved and functional. They will visit the study site twice a year for a Brain Motor Control Assessment, during which different stimulator settings will be tested to observe their effects on muscle activation. The study includes no masking or placebo groups and focuses on measuring voluntary electromyography (EMG) power changes during these assessments. Over the 10 years of participation, individuals will undergo regular evaluations including the Brain Motor Control Assessment, spinal imaging of the stimulator system, and monitoring of device function and health status. Researchers will track changes in voluntary EMG power as the primary outcome and also study participants' preferences for stimulation power. Participants must be medically stable and able to complete informed consent, with ongoing safety and rehabilitation monitoring to support their involvement throughout the study duration.

CONDITIONS

Brief Title

Epidural Stimulation After Neurologic Damage: Long-Term Outcomes

Who Can Participate

Age: 22Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 22 years of age or older
  • Able to undergo the informed consent process
  • Stable spinal cord injury
  • Neurologic level of injury below C5 as defined by ISNCSCI
  • No ventilator dependency within the last year
  • American Spinal Injury Association impairment scale "A" or "B" without spinal cord stimulation
  • Medically stable as determined by the principal investigator
  • More than 1 year since initial injury and at least 6 months since any spinal instrumentation and 2 months since spinal cord stimulator surgery
  • Existing, functional, FDA-approved implanted spinal cord stimulator system
  • Spinal imaging confirming the implanted stimulator system
Not Eligible

You will not qualify if you...

  • Current or expected need for opioid pain medications or pain preventing full rehabilitation participation
  • Botulinum toxin (Botox) injections within the previous six months
  • Clinically significant mental illness as judged by the principal investigator
  • Other medical conditions or medications preventing participation in testing or rehabilitation
  • Nonfunctional or near end-of-life spinal cord stimulator
  • Current pregnancy
  • Current pain relief from spinal cord stimulator if originally implanted for chronic pain management

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 10 years

Participants have an implanted epidural spinal cord stimulator device that is used during the trial to provide stimulation from the epidural space.

2 visits per year (in-person) for the Brain Motor Control Assessment

Trial Site Locations

Total: 1 location

1

Hennepin County Medical Center

Minneapolis, Minnesota, United States, 55415

Actively Recruiting

Loading map...

Research Team

S

Study Coordinator

S

Study Coordinator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Novel Repetitive Synchronized Associative Stimulation Neur...

SCI - Spinal Cord Injury

Actively Recruiting

1 location

ARC-IM Therapy To Support and Promote Recovery of Ambulatory...

Spinal Cord Injury

Actively Recruiting

2 locations

Differential Assessment of Hypertonia Related to Central Ner...

SCI - Spinal Cord Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here